- Home
- LNTH
as 12-20-2024 4:00pm EST
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | NORTH BILLERICA |
| Market Cap: | 6.3B | IPO Year: | 2015 |
| Target Price: | $132.67 | AVG Volume (30 days): | 994.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 6.02 | EPS Growth: | 304.57 |
| 52 Week Low/High: | $50.20 - $126.89 | Next Earning Date: | 11-06-2024 |
| Revenue: | $1,496,799,000 | Revenue Growth: | 24.15% |
| Revenue Growth (this year): | 19.56% | Revenue Growth (next year): | 3.94% |
Stock Insider Trading Activity of Lantheus Holdings Inc. (LNTH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Marshall Robert J. Jr. | LNTH | CFO and Treasurer | Nov 15 '24 | Sell | $81.20 | 10,000 | $812,000.00 | 102,963 | |
| Blanchfield Paul | LNTH | President | Nov 14 '24 | Sell | $79.65 | 2,000 | $159,300.00 | 97,092 | |
| Heino Mary Anne | LNTH | Director | Nov 8 '24 | Sell | $87.90 | 11,487 | $1,001,217.84 | 447,436 |
Latest Lantheus Holdings Inc. News
LNTH Breaking Stock News: Dive into LNTH Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Lantheus Holdings CMO Jeff Humphrey to Depart
MT Newswires
3 days ago
Goldman Sachs Initiates Coverage on Lantheus Holdings With Buy Rating, $143 Price Target
Argus Research
4 days ago
LNTH: Raising target price to $97.00
Insider Monkey
5 days ago
Lantheus Holdings, Inc. (LNTH): A Bull Case Theory
Argus Research
11 days ago
LNTH: Raising target price to $96.00
Argus Research
18 days ago
LNTH: Lowering target price to $93.00
Simply Wall St.
18 days ago
Is Weakness In Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Zacks Small Cap Research
18 days ago
LNTH: Initiating Coverage - A Glowing Recommendation
Compare LNTH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LNTH Lantheus Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.